zinc oxide has been researched along with ellagic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Ali, SH; Hakim, MN; Hussein, MZ; Zainal, Z | 1 |
| Chen, C; Gong, X; Huang, X; Jiang, N; Li, S; Xiao, Z; Yi, C; Yu, C; Zheng, X; Zhu, X | 1 |
2 other study(ies) available for zinc oxide and ellagic acid
| Article | Year |
|---|---|
Development of antiproliferative nanohybrid compound with controlled release property using ellagic acid as the active agent.
Topics: Adsorption; Animals; Cell Survival; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Ellagic Acid; Hepatocytes; Nanocomposites; Particle Size; Porosity; Powder Diffraction; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Zinc Oxide | 2011 |
Transdermal BQ-788/EA@ZnO quantum dots as targeting and smart tyrosinase inhibitors in melanocytes.
Topics: Administration, Cutaneous; Adult; Biocompatible Materials; Cells, Cultured; Delayed-Action Preparations; Drug Delivery Systems; Ellagic Acid; Endocytosis; Enzyme Inhibitors; Humans; Melanins; Melanocytes; Monophenol Monooxygenase; Oligopeptides; Piperidines; Quantum Dots; Tyrosine; Zinc Oxide | 2019 |